Apeloa Pharmaceutical to Form Joint Venture with Related Parties for Biopharmaceutical Expansion

Stock News07-16

Apeloa Pharmaceutical Co.,Ltd. (SHE: 000739) has announced plans to establish a joint venture with related parties, aiming to foster the long-term development of its core business, expand its biopharmaceutical operations, and enhance its overall competitiveness.

The company intends to use its own funds to co-invest with related parties, including Hengdian Co., Ltd. and Dongyang Zhenyutai Enterprise Management Partnership, to set up "Zhejiang Anteyutai Biotechnology Co., Ltd." (referred to as "Anteyutai"). The registered capital for the new venture is set at 10 million yuan.

Under the arrangement, Apeloa Pharmaceutical plans to contribute a capital subscription of 3.4578 million yuan, which will grant it a 34.578% equity stake in Anteyutai.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment